The RSV vaccine protects against respiratory syncytial virus, a common cause of chest and lung infections. It is mainly recommended for older adults and during pregnancy to protect newborn babies.
£225 per dose — single-dose course
Who it is for
Older adults and people during pregnancy to protect newborn babies
Number of doses
A single dose
When to have it
Ideally before the autumn and winter RSV season
How long protection lasts
Several years from a single dose (trial data show at least two seasons)
How it is given
An injection into the upper arm
Price
£225 per dose
The RSV vaccine protects against respiratory syncytial virus, a common cause of serious chest and lung infections. It is mainly recommended for older adults and can be given during pregnancy to protect newborn babies, rather than for travel. The RSV vaccine is available at Crewe Travel Clinic in Crewe, Cheshire.
Respiratory syncytial virus (RSV) is a common virus that causes infections of the lungs and airways. In most people it leads to mild, cold-like symptoms, but in older adults and very young infants it can cause more serious chest infections such as bronchiolitis and pneumonia.
The virus spreads easily through coughs, sneezes and close contact, and tends to circulate most during the autumn and winter months. Older people and those with underlying heart or lung conditions are at greater risk of severe illness.
The RSV vaccine helps the body build protection and is usually given as a single dose. It is offered to older adults and may be given during pregnancy to help protect newborn babies in their first months of life. Our clinician will assess your age, health or pregnancy and individual circumstances to advise whether vaccination is suitable for you.
Ideally before RSV season
The vaccine is ideally given ahead of the autumn and winter season when RSV circulates most, and in pregnancy it is given to help protect the baby after birth.
Good level of protection
The vaccine provides good protection against serious RSV-related chest infections in older adults, and vaccination in pregnancy helps protect newborn babies in their early months.
Several years from a single dose
A single dose is designed to provide protection across multiple RSV seasons, with current trial data showing protection lasting at least two years; there is currently no recommendation for revaccination after the first dose.
RSV vaccination is mainly recommended for older adults and may be given during pregnancy to protect newborn babies in their first months. It is especially relevant for those at greater risk of severe chest infections, including people with underlying heart or lung conditions. Our clinician will assess your age, health or pregnancy before recommending it.
RSV vaccination is mainly recommended for older adults and may be advised during pregnancy to help protect newborn babies in their first months of life. It is particularly relevant for people at greater risk of severe chest infections. A clinician will assess your age, health and pregnancy status before recommending vaccination.
The RSV vaccine is given as a single dose, delivered as an injection into the upper arm. It is ideally given ahead of the autumn and winter months, when RSV circulates most. In pregnancy it is timed to help pass protection to the baby before birth.
A single dose is designed to provide protection across more than one RSV season. Current trial data show good protection against serious RSV-related chest infections lasting at least two years, and there is no current recommendation for revaccination.
Most side effects are mild and settle within a few days. Serious reactions are rare. A clinician will discuss any individual considerations with you before vaccination and advise on what to expect afterwards.